NSCLC |
Non-small cell lung cancer |
SCLC |
Small-cell lung carcinoma |
DPIs |
Dry-powder inhalers |
Dae
|
Aerodynamic diameter |
EPR |
Enhanced permeability and retention |
PLGA |
Polylactic-co-glycolic |
PEG |
Polyethylene glycol |
CD-RES NP |
Resveratrol-cyclodextrin nanoparticles |
SF |
Sorafenib |
PLA |
Poly-L-arginine |
DOX |
Doxorubicin |
AQ |
Amodiaquine |
HPH |
High-pressure homogenization |
BSA |
Bovine serum albumin |
PEI |
Polyethyleneimine |
Cs |
Chitosan |
F |
Fucoidan |
HTCC |
N-[(2-hydroxy-3- trimethylammonium)propyl] chitosan chloride |
SLNs |
Solid lipid nanoparticles |
LPN |
Lipid–polymer hybrid nanoparticles |
NLCs |
Nanostructured lipid carriers |
SD |
Sprague–Dawley |
PFD |
Pirfenidone |
PTX |
Paclitaxel |
DLPC |
Dilauroylphosphatidyl choline |
CLH |
Hydroxycamptothecin |
5-ALA |
5-aminolevulinic acid |
5-FU |
5-Fluorouracil |
DPPC |
Dipalmitoyl phosphatidylcholine |
DPPG |
Dipalmitoyl phosphatidylglycerol |
DPPA |
Dipalmitoyl phosphatidic acid |
NEs |
Nanoemulsions |
PDI |
Polydispersity index |
LDH |
Lactate dehydrogenase |
CU |
Curcumin |
DOTAP |
(N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium) or 1, 2-dioleoyl-3-trimethylammonium propane |
LPHNs |
Lipid–polymer hybrid nanoparticles |
DLPC |
Dilauroylphosphatidylcholine |
9NC |
9-Nitrocamptothecin |
GPs |
Gelatin nanoparticles |
MNPs |
Magnetic nanoparticles |
MSNs |
Mesoporous silica NPs |
ZnO-NPs |
Zinc oxide nanoparticles |
Cp |
Cisplatin |
Sb-GNPs |
Gemcitabine (Gem) silibinin-loaded gold nanoparticles |
CMC |
Critical micellar concentration |
DTX |
Docetaxel |
pMDIs |
Pressurized metered-dose inhalers |